Literature DB >> 22469626

α-Synuclein knockout mice have cognitive impairments.

V S Kokhan1, M A Afanasyeva, G I Van'kin.   

Abstract

α-Synuclein is a member of the synuclein family of cytoplasmic, predominantly neuron-specific proteins. Considerable amount of α-synuclein is found in axons and presynaptic terminals of neurons located in brain areas responsible for emotions and memory. In the present study we have carried out behavioral evaluation of spatial and working long-term memory of α-synuclein knockout mice. Our data shows that α-synuclein knockout mice have reduced learning ability in tests requiring both working and spatial memory. For the first time we have demonstrated that α-synuclein is necessary for these types of learning.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469626     DOI: 10.1016/j.bbr.2012.03.026

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  28 in total

Review 1.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

2.  Hypertension-induced synapse loss and impairment in synaptic plasticity in the mouse hippocampus mimics the aging phenotype: implications for the pathogenesis of vascular cognitive impairment.

Authors:  Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Stefano Tarantini; Andriy Yabluchanskiy; Gábor Fülöp; Tripti Gautam; Albert Orock; Anna Csiszar; Ferenc Deak; Zoltan Ungvari
Journal:  Geroscience       Date:  2017-06-29       Impact factor: 7.713

3.  Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies.

Authors:  Gaia Skibinski; Ken Nakamura; Mark R Cookson; Steven Finkbeiner
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

4.  PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.

Authors:  Lucia B Jilaveanu; Fabio Parisi; Meaghan L Barr; Christopher R Zito; William Cruz-Munoz; Robert S Kerbel; David L Rimm; Marcus W Bosenberg; Ruth Halaban; Yuval Kluger; Harriet M Kluger
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

5.  A Preliminary Study on Investigation of Serum α-Synuclein and Tau Protein Levels in Children with Attention Deficit Hyperactivity Disorder.

Authors:  Ihsan Cetin; Seref Simsek
Journal:  Indian J Clin Biochem       Date:  2016-08-03

Review 6.  Alpha-synuclein modulates dopamine neurotransmission.

Authors:  Brittany Butler; Danielle Sambo; Habibeh Khoshbouei
Journal:  J Chem Neuroanat       Date:  2016-06-19       Impact factor: 3.052

7.  Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.

Authors:  Tessandra Stewart; Changqin Liu; Carmen Ginghina; Kevin C Cain; Peggy Auinger; Brenna Cholerton; Min Shi; Jing Zhang
Journal:  Am J Pathol       Date:  2014-03-11       Impact factor: 4.307

Review 8.  Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.

Authors:  Rafael Franco; Rafael Rivas-Santisteban; Gemma Navarro; Annalisa Pinna; Irene Reyes-Resina
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

9.  Differential involvement of the gamma-synuclein in cognitive abilities on the model of knockout mice.

Authors:  Viktor S Kokhan; Gennadiy I Van'kin; Sergey O Bachurin; Inna Yu Shamakina
Journal:  BMC Neurosci       Date:  2013-05-14       Impact factor: 3.288

10.  Pax6 interactions with chromatin and identification of its novel direct target genes in lens and forebrain.

Authors:  Qing Xie; Ying Yang; Jie Huang; Jovica Ninkovic; Tessa Walcher; Louise Wolf; Ariel Vitenzon; Deyou Zheng; Magdalena Götz; David C Beebe; Jiri Zavadil; Ales Cvekl
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.